Ann: AHI Letter to Shareholders, page-19

First 19 Last

Share
Profile

Follow
Tradingasx

1,099 Posts.

652

23/02/22

07:42

Post #: 59748398
Share

Originally posted by SERA2g: ↑

I'm still long on AHI and I haven't "given up" on it so to speak but after a year and a half of failed promises, binding agreements that haven't eventuated into any revenue at all and several of what I would largely consider company orchestrated pumps via Scholz and Danny (don't even try to deny) it's hard to not be outwardly frustrated and disappointed

Vlado speaks in one tone only and that's a tone of positivity, which is great when things are going well, but it leaves a lot to be desired when things aren't going well.

I've seen AHI at $2+ and now we're at 27c so I'd say things aren't going well at all and Vlado's empty promises were one too many.

If the failing share price isnt already enough to put shareholders offside, the board choosing to appoint Vlado's significant other as the CEO is a huge slap in the face.

Name me one company where the outgoing CEO (under circumstances such as Vlados - bankruptcy) hasn't been replaced by someone on the board as interim CEO until the board can conduct an appropriate search for a replacement or formally appoint the interim CEO as CEO.

AHI instead choose someone that is not only not on the board but is also the significant other of the outgoing CEO, which not only defies logic but also is a huge middle finger to the Corporations Act of which the board is suppose to have a fiduciary duty.

While we're on the topic of remembering excitement around AHI, "AHI $10", "Vlado's a genius". I won't be the only
one here that remembers who said those statements time and time again.

Expand

Well said, couldn’t have worded it better.

completely agree with this comment, one the most honest and accurate posted in these threads.

I hope you are ok (I mean that too).

AHI Price at posting: 27.0¢ Sentiment: None Disclosure: Not Held
5 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 113 more messages in this thread...

First 19 Last

Add AHI (ASX) to my watchlist

(20min delay)
Last 9.2¢		Change 0.000(0.00%)		Mkt cap ! $24.77M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: AHI Letter to Shareholders, page-19

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Featured News

Ann: AHI Letter to Shareholders, page-19

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Featured News